Re: [新聞] 智擎最新胰臟癌新藥進度
大家所關心的藥證申請進度
網址: http://ppt.cc/mJh2
In November 2014, the FDA granted MM-398 plus 5-FU and leucovorin a Fast
Track designation as a second-line treatment for patients with metastatic
pancreatic cancer, based on data from the NAPOLI-1 study. As part of this
review program, the company developing MM-298, Merrimack Pharmaceuticals, can
submit information for a New Drug Application for MM-398 to the FDA in
sections. The company plans to complete this submission process within the
first few months of 2015.
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 223.136.76.18
※ 文章網址: https://www.ptt.cc/bbs/Stock/M.1421571408.A.281.html
推
01/18 17:14, , 1F
01/18 17:14, 1F
推
01/18 17:24, , 2F
01/18 17:24, 2F
推
01/18 17:28, , 3F
01/18 17:28, 3F
推
01/18 17:49, , 4F
01/18 17:49, 4F
→
01/18 17:52, , 5F
01/18 17:52, 5F
推
01/18 17:55, , 6F
01/18 17:55, 6F
推
01/18 17:55, , 7F
01/18 17:55, 7F
推
01/18 18:01, , 8F
01/18 18:01, 8F
推
01/18 18:37, , 9F
01/18 18:37, 9F
推
01/18 19:39, , 10F
01/18 19:39, 10F
推
01/18 20:15, , 11F
01/18 20:15, 11F
推
01/18 20:45, , 12F
01/18 20:45, 12F
→
01/18 20:45, , 13F
01/18 20:45, 13F
推
01/18 21:00, , 14F
01/18 21:00, 14F
推
01/18 21:51, , 15F
01/18 21:51, 15F
推
01/18 22:08, , 16F
01/18 22:08, 16F
討論串 (同標題文章)